Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam besylate sedation in frail elderly patients undergoing gastrointestinal endoscopy
ChiCTR2500095097Phase 4Not yet recruiting
- Sponsor
- Dazhou Central Hospital
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in None (2 arms), sponsored by Dazhou Central Hospital. Primary endpoints: Incidence of hypoxemia and Depression of respiration. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2500095097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095097.